KROS logo

Keros Therapeutics (KROS) Operating profit

annual operating profit:

-$209.59M-$42.05M(-25.10%)
December 31, 2024

Summary

  • As of today (June 18, 2025), KROS annual operating income is -$209.59 million, with the most recent change of -$42.05 million (-25.10%) on December 31, 2024.
  • During the last 3 years, KROS annual operating profit has fallen by -$153.22 million (-271.80%).
  • KROS annual operating profit is now -15766.39% below its all-time high of -$1.32 million, reached on December 31, 2018.

Performance

KROS Operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKROSincome statement metrics

quarterly operating profit:

$152.04M+$204.06M(+392.29%)
March 31, 2025

Summary

  • As of today (June 18, 2025), KROS quarterly operating income is $152.04 million, with the most recent change of +$204.06 million (+392.29%) on March 31, 2025.
  • Over the past year, KROS quarterly operating profit has increased by +$200.52 million (+413.59%).
  • KROS quarterly operating profit is now at all-time high.

Performance

KROS quarterly operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKROSincome statement metrics

TTM operating profit:

-$9.07M+$200.52M(+95.67%)
March 31, 2025

Summary

  • As of today (June 18, 2025), KROS TTM operating income is -$9.07 million, with the most recent change of +$200.52 million (+95.67%) on March 31, 2025.
  • Over the past year, KROS TTM operating profit has increased by +$168.08 million (+94.88%).
  • KROS TTM operating profit is now -238.76% below its all-time high of -$2.68 million, reached on March 31, 2019.

Performance

KROS TTM operating profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherKROSincome statement metrics

Operating profit Formula

Operating Profit = Gross Profit − Operating Expenses

KROS Operating profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-25.1%+413.6%+94.9%
3 y3 years-271.8%+730.2%+86.0%
5 y5 years-1994.9%+1547.5%+49.1%

KROS Operating profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-271.8%at lowat high+359.2%at high+95.7%
5 y5-year-1994.9%at lowat high+359.2%at high+95.7%
alltimeall time<-9999.0%at lowat high+359.2%-238.8%+95.7%

KROS Operating profit History

DateAnnualQuarterlyTTM
Mar 2025
-
$152.04M(-392.3%)
-$9.07M(-95.7%)
Dec 2024
-$209.59M(+25.1%)
-$52.02M(-11.3%)
-$209.59M(+3.9%)
Sep 2024
-
-$58.66M(+16.3%)
-$201.63M(+8.3%)
Jun 2024
-
-$50.44M(+4.0%)
-$186.26M(+5.1%)
Mar 2024
-
-$48.48M(+10.1%)
-$177.16M(+5.7%)
Dec 2023
-$167.54M(+55.5%)
-$44.05M(+1.8%)
-$167.54M(+7.8%)
Sep 2023
-
-$43.28M(+4.7%)
-$155.45M(+13.9%)
Jun 2023
-
-$41.34M(+6.3%)
-$136.44M(+11.4%)
Mar 2023
-
-$38.87M(+21.6%)
-$122.45M(+13.7%)
Dec 2022
-$107.71M(+91.1%)
-$31.96M(+31.7%)
-$107.71M(+33.6%)
Sep 2022
-
-$24.27M(-11.3%)
-$80.61M(+5.3%)
Jun 2022
-
-$27.35M(+13.4%)
-$76.54M(+18.2%)
Mar 2022
-
-$24.13M(+395.8%)
-$64.73M(+14.8%)
DateAnnualQuarterlyTTM
Dec 2021
-$56.37M(+27.5%)
-$4.87M(-75.9%)
-$56.37M(-9.6%)
Sep 2021
-
-$20.20M(+30.0%)
-$62.34M(+15.3%)
Jun 2021
-
-$15.54M(-1.4%)
-$54.09M(+9.4%)
Mar 2021
-
-$15.77M(+45.6%)
-$49.46M(+11.9%)
Dec 2020
-$44.20M(+341.7%)
-$10.83M(-9.3%)
-$44.20M(+22.4%)
Sep 2020
-
-$11.95M(+9.5%)
-$36.09M(+36.3%)
Jun 2020
-
-$10.91M(+3.9%)
-$26.47M(+48.5%)
Mar 2020
-
-$10.50M(+285.0%)
-$17.83M(+78.2%)
Dec 2019
-$10.01M(+657.4%)
-$2.73M(+17.3%)
-$10.01M(+37.5%)
Sep 2019
-
-$2.33M(+2.3%)
-$7.28M(+47.0%)
Jun 2019
-
-$2.27M(-15.1%)
-$4.95M(+84.9%)
Mar 2019
-
-$2.68M
-$2.68M
Dec 2018
-$1.32M
-
-

FAQ

  • What is Keros Therapeutics annual operating income?
  • What is the all time high annual operating profit for Keros Therapeutics?
  • What is Keros Therapeutics annual operating profit year-on-year change?
  • What is Keros Therapeutics quarterly operating income?
  • What is the all time high quarterly operating profit for Keros Therapeutics?
  • What is Keros Therapeutics quarterly operating profit year-on-year change?
  • What is Keros Therapeutics TTM operating income?
  • What is the all time high TTM operating profit for Keros Therapeutics?
  • What is Keros Therapeutics TTM operating profit year-on-year change?

What is Keros Therapeutics annual operating income?

The current annual operating profit of KROS is -$209.59M

What is the all time high annual operating profit for Keros Therapeutics?

Keros Therapeutics all-time high annual operating income is -$1.32M

What is Keros Therapeutics annual operating profit year-on-year change?

Over the past year, KROS annual operating income has changed by -$42.05M (-25.10%)

What is Keros Therapeutics quarterly operating income?

The current quarterly operating profit of KROS is $152.04M

What is the all time high quarterly operating profit for Keros Therapeutics?

Keros Therapeutics all-time high quarterly operating income is $152.04M

What is Keros Therapeutics quarterly operating profit year-on-year change?

Over the past year, KROS quarterly operating income has changed by +$200.52M (+413.59%)

What is Keros Therapeutics TTM operating income?

The current TTM operating profit of KROS is -$9.07M

What is the all time high TTM operating profit for Keros Therapeutics?

Keros Therapeutics all-time high TTM operating income is -$2.68M

What is Keros Therapeutics TTM operating profit year-on-year change?

Over the past year, KROS TTM operating income has changed by +$168.08M (+94.88%)
On this page